Adjunct therapies after botulinum toxin injections in spastic adults: Systematic review and SOFMER recommendations

Allart, Étienne; Idée, Stéphane; Boyer, Françoise

doi:10.1016/j.rehab.2021.101544

Cited by 10 publications

(10 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Both casting and adhesive taping were shown to significantly improve the effects of botulinum toxin in managing upper and lower limb spasticity [ 157 ]. Allart et al further explored the effectiveness of various adjunctive therapies alongside botulinum toxin injections for the treatment of spasticity [ 158 ]. Their study encompassed joint posture procedures, including both continuous techniques, such as taping and casting, and discontinuous methods, such as splinting and manual stretching.…”

Section: Discussionmentioning

confidence: 99%

“…They also explored the use of physical agents, such as electrical stimulation, muscle vibration, and shockwave therapy, but advised against these due to limited efficacy. Additionally, the study considered active adjunct therapies, including high-intensity device-assisted methods, and soft posture techniques, such as compression sleeves and kinesiotaping, although these were found to be less effective [ 158 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis

Facciorusso,

Spina,

Picelli

et al. 2024

Toxins

View full text Add to dashboard Cite

Botulinum toxin type-A (BoNT-A) has emerged as a key therapeutic agent for the management of spasticity. This paper presents a comprehensive bibliometric and visual analysis of research concerning BoNT-A treatment of spasticity to elucidate current trends and future directions in this research area. A search was conducted in the Web of Science database for articles focused on the use of BoNT-A in spasticity published between 2000 and 2022. We extracted various metrics, including counts of publications and contributions from different countries, institutions, authors, and journals. Analytical methods in CiteSpace were employed for the examination of co-citations, collaborations, and the co-occurrence of keywords. Our search yielded 1489 publications. Analysis revealed a consistent annual increase in research output. The United States, United Kingdom, and Italy were the leading contributors. The top institution in this research was Assistance Publique Hopitaux, Paris. The journal containing the highest number of relevant publications was Toxins. Key frequently occurring keywords were ‘stroke’, ‘cerebral palsy’, ‘adult spasticity’, and ‘upper extremity’. This study identified 12 clusters of keywords and 15 clusters of co-cited references, indicating the main focus areas and emerging themes in this field. This study comprehensively analyzed and summarized trends in BoNT-A research in the field of spasticity over the past 22 years.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis

Facciorusso,

Spina,

Picelli

et al. 2024

Toxins

View full text Add to dashboard Cite

show abstract

“…This window permits the toxin to achieve its clinically active phase while also permitting patients to select a timeframe where wearing a cast does not disrupt their activities of daily living or other scheduled activities. A 2022 survey, conducted in France, found that among participating spasticity experts, 76% agreed with this practice 16 . To improve patient outcomes, the implementation of a multimodal program is recommended, which includes slow passive muscle stretching with a neurophysiotherapist after the BoNT injection and before casting to maximize the benefits of the treatment.…”

Section: Methodsmentioning

confidence: 99%

“…A 2022 survey, conducted in France, found that among participating spasticity experts, 76% agreed with this practice. 16 To improve patient outcomes, the implementation of a multimodal program is recommended, which includes slow passive muscle stretching with a neurophysiotherapist after the BoNT injection and before casting to maximize the benefits of the treatment.…”

Section: Baseline Assessment and Timelinementioning

confidence: 99%

Upper Limb Casting Application Post-Botulinum Toxin Injection for Elbow Spasticity: A Guided Casting Protocol

WORTLEY,

CARDA,

GANZERT

et al. 2024

Am J Phys Med Rehabil

View full text Add to dashboard Cite

Casting is an effective adjunctive treatment which increases the effects of botulinum toxin on patients with spasticity. The evidence for casting as an adjunctive therapy post-botulinum toxin has been well documented in the literature. However, standardized casting protocols are lacking, with no published descriptions of upper limb casting application post-botulinum toxin injection for spasticity. In this paper we will describe our experience regarding the application of upper limb casting as an adjunctive therapy for elbow spasticity, detailing indications, contraindications and description of our protocol (materials required and technique).

show abstract

“…It should be stated that BTA in HSP is not a stand-alone therapy. Although they are not the scope of this article, adjunct therapies, such as stretching and active or passive physiotherapy techniques, may improve the treatment results [18].…”

Section: Introductionmentioning

confidence: 99%

The Place of Botulinum Toxin in Spastic Hemiplegic Shoulder Pain after Stroke: A Scoping Review

Struyf

Triccas

Schillebeeckx

et al. 2023

IJERPH

View full text Add to dashboard Cite

Stroke is a common pathology worldwide, with an age-standardized global rate of new strokes of 150.5 per 100,000 population in 2017. Stroke causes upper motor neuron impairment leading to a spectrum of muscle weakness around the shoulder joint, changes in muscle tone, and subsequent soft tissue changes. Hemiplegic shoulder pain (HSP) is the most common pain condition in stroke patients and one of the four most common medical complications after stroke. The importance of the appropriate positioning and handling of the hemiplegic shoulder for prevention of HSP is therefore of high clinical relevance. Nevertheless, HSP remains a frequent and disabling problem after stroke, with a 1-year prevalence rate up to 39%. Furthermore, the severity of the motor impairment is one of the most important identified risk factors for HSP in literature. Spasticity is one of these motor impairments that is likely to be modifiable. After ruling out or treating other shoulder pathologies, spasticity must be assessed and treated because it could lead to a cascade of unwanted complications, including spastic HSP. In clinical practice, Botulinum toxin A (BTA) is regarded as the first-choice treatment of focal spasticity in the upper limb, as it gives the opportunity to target specifically selected muscles. It thereby provides the possibility of a unique patient tailored focal and reversible treatment for post stroke spasticity. This scoping review aims to summarize the current evidence of BTA treatment for spastic HSP. First, the clinical manifestation and outcome measures of spastic HSP will be addressed, and second the current evidence of BTA treatment of spastic HSP will be reviewed. We also go in-depth into the elements of BTA application that may optimize the therapeutic effect of BTA. Finally, future considerations for the use of BTA for spastic HSP in clinical practice and research settings will be discussed.

show abstract

Adjunct therapies after botulinum toxin injections in spastic adults: Systematic review and SOFMER recommendations

Cited by 10 publications

References 46 publications

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis

Upper Limb Casting Application Post-Botulinum Toxin Injection for Elbow Spasticity: A Guided Casting Protocol

The Place of Botulinum Toxin in Spastic Hemiplegic Shoulder Pain after Stroke: A Scoping Review

Contact Info

Product

Resources

About